Éxitos y retos para el control de la toxoplasmosis congénita en Colombia

Cruz-Agudelo C, Bedoya M, Rodriguez Padilla Libia, Campo-Campo M, Sanin-Blair J, Londoño-Montoya J, et al. Toxoplasmosis gestacional: desenlaces obstétricos y resultados perinatales en un hospital de referencia en Medellín, Colombia. 2015-2021. Un estudio descriptivo. Infectio 2023;27(4): 222-228.

Mejia-Oquendo M, Marulanda-Ibarra E, Gomez-Marin JE. Evaluation of the impact of the first evidence-based guidelines for congenital toxoplasmosis in Armenia (Quindío) Colombia: An observational retrospective analysis. The Lancet Regional Health - Americas 2021;1:100010. https://doi.org/10.1016/j.lanepe.2020.100010

Gómez-Marin JE, De-la-Torre A, Angel-Muller E, Rubio J, Arenas J, Osorio E, et al. First Colombian Multicentric Newborn Screening for Congenital Toxoplasmosis. PLoS Negl Trop Dis 2011;5:e1195. https://doi.org/10.1371/journal.pntd.0001195.

Chicaíza-becerra L, García-Molina M, Oviedo-ariza S, Gómez-Marín JE, Gómez-Sánchez PI. Costo efectividad de diferentes estrategias diagnósticas para detección de toxoplasmosis congénita en el recién nacido. Infectio 2013;17:53-60. https://doi.org/10.1016/S0123-9392(13)70163-2

Gómez Marin JE. Necesidad de una farmacia nacional: un problema de seguridad nacional. Infectio 2016;20:1-2. https://doi.org/10.1016/j.infect.2015.08.001. https://doi.org/10.3233/JPN2010-0380

Pathmanathan U, Halgrain D, Chiadmi F, Schlatter J, Vermerie N. Stability of sulfadiazine oral liquids prepared from tablets and powder. J Pharm Pharm Sci 2004;7:84-7.

Ferreira AO, Polonini HC, Silva SL, Patrício FB, Brandão MAF, Raposo NRB. Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend® SF PH4 oral suspensions. J Pharm Biomed Anal 2016;118:105-12. https://doi.org/10.1016/j.jpba.2015.10.032

Stability of sulfadiazine oral liquids prepared from tablets and powder. n.d. https://sites.ualberta.ca/~csps/JPPS7(1)/J.Schlatter/sulfadiazine..htm (accessed February 25, 2023). https://doi.org/10.1017/S0956618X23000297

Londoño-Martinez JC, Velasco-Velasquez S, Cordero-Lopez S, Osorio MF, Celis-Giraldo D, Thibodeau J, et al. Evaluation of the acceptability of point of care diagnostic test for prenatal toxoplasmosis (translational research phase III). J Infect Public Health 2023;16:15-24. https://doi.org/10.1016/j.jiph.2022.11.023

Gomez CA, Budvytyte LN, Press C, Zhou L, McLeod R, Maldonado Y, et al. Evaluation of three point-of-care tests for detection of Toxoplasma immunoglobulin IgG and IgM in the United States: Proof of concept and challenges. Open Forum Infect Dis 2018;5. https://doi.org/10.1093/ofid/ofy215.